Biomarkers in pancreas transplant

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Purpose of review The review analyzes the current biomarkers used in monitoring pancreas transplant, from the simple and time-tested, to more sophisticated, including markers of allo-and autoimmunity, that are likely to play a larger role in future studies. Recent findings Evaluation of alloimmunity includes serum levels of donor-specific antibody, and, ultimately, pancreas transplant biopsies with C4d staining. Our center has focused on markers of autoimmunity, including assessment of autoantibodies and autoreactive T cells. We have found that conversion of autoantibodies (including GAD65, IA-2, and ZnT8), or the development of a new positive autoantibody, particularly ZnT8, are associated with type 1 diabetes (T1D) recurrence in the pancreas transplant. Autoreactive T cells have also been identified in the peripheral blood, pancreas transplant and peripancreas transplant-lymph nodes, that have the potential to mediate human b/islet cell destruction in vivo. Summary The monitoring of pancreas transplant biomarkers, particularly those associated with autoimmunity, has led to new insights into the pathogenesis of T1D. Progress in the elucidation of mechanisms of autoimmunity may lead to novel therapeutic approaches to both T1D recurrence of the pancreas transplant and perhaps also new onset T1D.

Original languageEnglish (US)
Pages (from-to)412-418
Number of pages7
JournalCurrent Opinion in Organ Transplantation
Volume21
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Pancreas
Biomarkers
Transplants
Autoimmunity
Type 1 Diabetes Mellitus
Autoantibodies
T-Lymphocytes
Recurrence
Islets of Langerhans
Lymph Nodes
Staining and Labeling
Biopsy
Antibodies
Serum

Keywords

  • Autoantibodies
  • autoreactive T cells
  • pancreas transplant
  • recurrent autoimmunity
  • type 1 diabetes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation

Cite this

Biomarkers in pancreas transplant. / Burke, George W; Chen, Linda J; Ciancio, Gaetano; Pugliese, Alberto.

In: Current Opinion in Organ Transplantation, Vol. 21, No. 4, 01.08.2016, p. 412-418.

Research output: Contribution to journalReview article

@article{cbce4ac1aa3e4a089c84364e9684e809,
title = "Biomarkers in pancreas transplant",
abstract = "Purpose of review The review analyzes the current biomarkers used in monitoring pancreas transplant, from the simple and time-tested, to more sophisticated, including markers of allo-and autoimmunity, that are likely to play a larger role in future studies. Recent findings Evaluation of alloimmunity includes serum levels of donor-specific antibody, and, ultimately, pancreas transplant biopsies with C4d staining. Our center has focused on markers of autoimmunity, including assessment of autoantibodies and autoreactive T cells. We have found that conversion of autoantibodies (including GAD65, IA-2, and ZnT8), or the development of a new positive autoantibody, particularly ZnT8, are associated with type 1 diabetes (T1D) recurrence in the pancreas transplant. Autoreactive T cells have also been identified in the peripheral blood, pancreas transplant and peripancreas transplant-lymph nodes, that have the potential to mediate human b/islet cell destruction in vivo. Summary The monitoring of pancreas transplant biomarkers, particularly those associated with autoimmunity, has led to new insights into the pathogenesis of T1D. Progress in the elucidation of mechanisms of autoimmunity may lead to novel therapeutic approaches to both T1D recurrence of the pancreas transplant and perhaps also new onset T1D.",
keywords = "Autoantibodies, autoreactive T cells, pancreas transplant, recurrent autoimmunity, type 1 diabetes",
author = "Burke, {George W} and Chen, {Linda J} and Gaetano Ciancio and Alberto Pugliese",
year = "2016",
month = "8",
day = "1",
doi = "10.1097/MOT.0000000000000333",
language = "English (US)",
volume = "21",
pages = "412--418",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Biomarkers in pancreas transplant

AU - Burke, George W

AU - Chen, Linda J

AU - Ciancio, Gaetano

AU - Pugliese, Alberto

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Purpose of review The review analyzes the current biomarkers used in monitoring pancreas transplant, from the simple and time-tested, to more sophisticated, including markers of allo-and autoimmunity, that are likely to play a larger role in future studies. Recent findings Evaluation of alloimmunity includes serum levels of donor-specific antibody, and, ultimately, pancreas transplant biopsies with C4d staining. Our center has focused on markers of autoimmunity, including assessment of autoantibodies and autoreactive T cells. We have found that conversion of autoantibodies (including GAD65, IA-2, and ZnT8), or the development of a new positive autoantibody, particularly ZnT8, are associated with type 1 diabetes (T1D) recurrence in the pancreas transplant. Autoreactive T cells have also been identified in the peripheral blood, pancreas transplant and peripancreas transplant-lymph nodes, that have the potential to mediate human b/islet cell destruction in vivo. Summary The monitoring of pancreas transplant biomarkers, particularly those associated with autoimmunity, has led to new insights into the pathogenesis of T1D. Progress in the elucidation of mechanisms of autoimmunity may lead to novel therapeutic approaches to both T1D recurrence of the pancreas transplant and perhaps also new onset T1D.

AB - Purpose of review The review analyzes the current biomarkers used in monitoring pancreas transplant, from the simple and time-tested, to more sophisticated, including markers of allo-and autoimmunity, that are likely to play a larger role in future studies. Recent findings Evaluation of alloimmunity includes serum levels of donor-specific antibody, and, ultimately, pancreas transplant biopsies with C4d staining. Our center has focused on markers of autoimmunity, including assessment of autoantibodies and autoreactive T cells. We have found that conversion of autoantibodies (including GAD65, IA-2, and ZnT8), or the development of a new positive autoantibody, particularly ZnT8, are associated with type 1 diabetes (T1D) recurrence in the pancreas transplant. Autoreactive T cells have also been identified in the peripheral blood, pancreas transplant and peripancreas transplant-lymph nodes, that have the potential to mediate human b/islet cell destruction in vivo. Summary The monitoring of pancreas transplant biomarkers, particularly those associated with autoimmunity, has led to new insights into the pathogenesis of T1D. Progress in the elucidation of mechanisms of autoimmunity may lead to novel therapeutic approaches to both T1D recurrence of the pancreas transplant and perhaps also new onset T1D.

KW - Autoantibodies

KW - autoreactive T cells

KW - pancreas transplant

KW - recurrent autoimmunity

KW - type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84976299629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976299629&partnerID=8YFLogxK

U2 - 10.1097/MOT.0000000000000333

DO - 10.1097/MOT.0000000000000333

M3 - Review article

C2 - 27348473

AN - SCOPUS:84976299629

VL - 21

SP - 412

EP - 418

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 4

ER -